LM Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$733K Buy
1,459
+735
+102% +$353K 0.08% 129
2026
Q1
$1.47K Sell
724
-141
-16% -$76.5K 0.02% 196
2025
Q4
$1.49K Sell
865
-1,667
-66% -$943K 0.03% 193
2025
Q3
$1.23M Sell
2,532
-29
-1% -$13.5K 0.18% 81
2025
Q2
$1.04M Sell
2,561
-261
-9% -$109K 0.13% 80
2025
Q1
$1.4M Sell
2,822
-2
-0.1% -$1.08K 0.25% 71
2024
Q4
$1.47M Sell
2,824
-418
-13% -$230K 0.26% 69
2024
Q3
$2M Buy
3,242
+1
+0% +$592 0.41% 47
2024
Q2
$1.79M Buy
3,241
+364
+13% +$209K 0.32% 59
2024
Q1
$2.68M Buy
2,877
+441
+18% +$247K 0.43% 45
2023
Q4
$1.29M Buy
+2,436
New +$1.18M 0.26% 66

Other funds holding TMO

LM Advisors's TMO Position: Q2 2026 in Review

LM Advisors increased its Thermo Fisher Scientific (TMO) stake by 102% in Q2 2026, buying an estimated $353K and bringing the position to 1,459 shares worth $733K. The position accounts for 0.08% of the portfolio, ranked #129.

LM Advisors first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.68M in Q1 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • LM Advisors held 1,459 shares of Thermo Fisher Scientific worth $733K as of Q2 2026.
  • LM Advisors bought 735 Thermo Fisher Scientific shares in Q2 2026, an estimated $353K.
  • Thermo Fisher Scientific made up 0.08% of LM Advisors's portfolio in Q2 2026, its #129 holding.
  • LM Advisors first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • LM Advisors's Thermo Fisher Scientific position peaked at $2.68M in Q1 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on LM Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.